The U.S. is changing. Are orthodontists ready for it?
In the U.S., the generational makeup is changing, and orthodontists need to shift as well seize practice expansion opportunities, according to the 2024 American Association
In the U.S., the generational makeup is changing, and orthodontists need to shift as well seize practice expansion opportunities, according to the 2024 American Association
Low-level laser therapy, which uses special lights to stimulate cell function, may offer immediate pain relief from burning mouth syndrome, according to a press release
Every week for more than a decade, Dr. Juan Yepes, MPH, DrPH, has provided case studies for HuangshanDental.com readers to use as a learning tool.
Incisors develop in the womb due to a buildup of mechanical pressure within the tissue, according to an animal study published in Nature Cell Biology.
Dental product and device company Pac-Dent Inc. launched the iMatrix Clear Sectional Matrix System at the 2024 Chicago Midwinter Dental Meeting. The new sectional system
Massachusetts may be the U.S. state with the best children’s health, in part due to it having the highest percentage of kids having medical and
Getting too few hours of sleep nightly may be associated with a significantly greater risk of developing periodontitis, according to a review recently published in
An artificial intelligence (AI)-powered toothbrush can improve oral hygiene levels and duration, particularly benefiting patients with periodontitis. This research was published in the Journal of
Having a higher body mass index (BMI) may not correlate with poorer jaw surgery outcomes or postoperative complications. This research was recently published in the
An oxygen saturation test may be a dependable way to evaluate pulp health two weeks after permanent teeth have been knocked out and replanted, according
Squirrels, beavers, and other rodents have orange-brown front teeth that may be key to developing oral care products that better protect human tooth enamel and
With more patients taking glucagonlike peptide 1 (GLP-1) agonists like Ozempic to control diabetes and obesity, clinicians may need to rethink how to manage them